Neon Therapeutics Inc. (NTGN)

March 19, 2019 EST.

Nasdaq Global Select : Healthcare

Prev Close 5.9

Price Open 5.86

Volume: 300

Avg Volume: 160,512

Market Cap: 167.15M

P/E Ratio -

52 Wk Range 4.2-16.23



NTGN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
27.31M
740,304
3.09
2.71%

2018-09-28
27.33M
570,516
3.66
2.09%

2018-09-14
27.33M
413,710
8.20
1.51%

2018-08-31
27.33M
383,555
11.72
1.40%




NTGN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-03-11
Q4 2018
N/A
-0.73 (3)
-0.84
-0.11

2019-02-11
Q4 2018
N/A
-0.73 (3)
0.00
0.00

2018-11-12
Q3 2018
N/A
-0.79 (3)
-0.67
0.12

2018-08-06
Q2 2018
N/A
-0.80 (2)
-7.84
-7.04

News

Neon Therapeutics reports Q4 results (2019-03-11 08:47 SeekingAlpha)

Neon Therapeutics (NASDAQ: NTGN ): Q4 GAAP EPS of -$0.84. Cash, cash equivalents and marketable securities $103.3M Press Release More news on: Neon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,

 


Statistics

Shares Outstanding: 28.33M

Top 15 Institution Percent: 87.50

Price To Sales: N/A

Price To Book: 1.63

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -81.44

Return On Equity: -2170.25

Profit Margin: N/A

Price History

Beta: 1.76

50-day Moving Avg: 5.19

200-day Moving Avg: 7.99

YTD Change: 16.83

5-day Change: -0.84

1-month Change: 27.43

3-month Change: 11.11

6-month Change: -32.34

1-year Change: -60.67

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Neon Therapeutics Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: https://neontherapeutics.com